Blood Lipids and Cognitive Performance of Aging Polish Adults: A Case-Control Study Based on the PolSenior Project
Open Access
- 17 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 12
Abstract
Background: The demand for effective strategies for maintaining cognitive capableness and establishing early dementia diagnosis has been tremendous, especially in the context of population aging. However, studies on the elderly population and neurocognitive impairment had provided ambiguous results throughout, while potential blood biomarkers of cognitive decline are yet to be clearly understood. Objectives: The present study is aimed at assessing the relationship between blood lipids—especially in the context of their usefulness as biomarkers of an early cognitive decline—and cognitive functioning of aging adults. Materials and Methods: The study sample consisted of 230 participants—(109 women, 121 men) aged 65+ years. Plasma 24(S)-hydroxycholesterol [24(S)-OHC], serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) were assessed. The analyses were conducted in three groups of cognitive performance: cognitively normal, mild cognitive impairment (MCI), and mild dementia, of which the subjects were divided with the Mini-Mental State Examination (MMSE). Results: No significant differences in 24(S)-OHC plasma concentrations for different levels of cognitive performance were found. Significant differences were found in serum TC (p = 0.026) and LDL (p = 0.007) concentrations for different levels of cognitive performance. Concentrations of both parameters were highest in the MCI group and lowest in mild dementia and cognitive norm, respectively. No significant differences between serum HDL concentrations and cognitive performance were found. Conclusions: To fully assess the potential of research on blood lipids in regards to a cognitive decline, cross-sectional or epidemiological studies aimed at further exploring blood lipid roles in both the early and advanced MCI and dementia, are needed.Keywords
This publication has 73 references indexed in Scilit:
- Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control studyBMC Neurology, 2011
- Statins and serum cholesterol's associations with incident dementia and mild cognitive impairmentJournal of Epidemiology and Community Health, 2010
- Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam StudyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort studyNeurology, 2008
- Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseCanadian Medical Association Journal, 2008
- Plasma Lipid Levels in the Elderly Are Not Associated with the Risk of Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2008
- Simvastatin is associated with a reduced incidence of dementia and Parkinson's diseaseBMC Medicine, 2007
- Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2001
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969